LB1528 - Results from ACTIV-6: A Decentralized, Double-Blinded, Randomized, Placebo-Controlled Platform Trial of Repurposed Drugs for the Treatment of Mild-to-Moderate COVID-19
Friday, October 21, 2022
1:45 PM – 1:55 PM US ET
Location: 209 ABC
All relevant financial disclosures have been mitigated.